Table 7.
Odds Ratio | 95% Confidence Intervals | Lambda | p-value | ||
---|---|---|---|---|---|
Lower | Upper | ||||
Age* | 0.988 | 0.985 | 0.991 | 0.256 | <0.001 |
Sex (Comparison Group: Male) | |||||
Female | 0.975 | 0.910 | 1.045 | 0.194 | 0.474 |
Race (Comparison Group: Caucasian) | |||||
Asian | 1.285 | 1.011 | 1.632 | 0.163 | 0.041 |
Black | 1.115 | 1.013 | 1.227 | 0.277 | 0.026 |
Hispanic | 1.264 | 1.096 | 1.460 | 0.235 | 0.001 |
Other | 0.942 | 0.778 | 1.140 | 0.136 | 0.536 |
Distress Score Quintile (Comparison Group: Prosperous) | |||||
Comfortable | 0.962 | 0.844 | 1.069 | 0.472 | 0.559 |
Mid-Tier | 0.920 | 0.813 | 1.042 | 0.417 | 0.192 |
At-Risk | 0.880 | 0.769 | 1.007 | 0.404 | 0.064 |
Distressed | 0.813 | 0.695 | 0.950 | 0.468 | 0.010 |
Zip Designation (Comparison Group: Urban) | |||||
Rural | 1.111 | 0.962 | 1.284 | 0441 | 0.153 |
Small town | 1.054 | 0.915 | 1.284 | 0.368 | 0.469 |
Suburban | 1.051 | 0.944 | 1.170 | 0.428 | 0.365 |
Insurance (Comparison Group: Other Non-Medicare/Medicaid Insurance) | |||||
Medicaid | 0.824 | 0.744 | 0.913 | 0.212 | <0.001 |
Medicare | 0.968 | 0.890 | 1.051 | 0.198 | 0.437 |
None | 0.597 | 0.496 | 0.717 | 0.354 | <0.001 |
Ejection fraction† | 0.937 | 0.933 | 0.941 | 0.190 | <0.001 |
Discharge Serum Creatinine* | 0.747 | 0.692 | 0.807 | 0.723 | <0.001 |
Discharge Serum Potassium (Comparison Group: K≤5) | |||||
K>5 | 0.887 | 0.679 | 1.158 | 0.562 | 0.379 |
Discharge Systolic Blood Pressure (Comparison Group: sBP≥90) | |||||
sBP<90 | 0.815 | 0.631 | 1.052 | 0.340 | 0.117 |
Discharge Heart Rate (Comparison Group: HR≥60) | |||||
HR<60 | 1.091 | 0.927 | 1.282 | 0.403 | 0.295 |
No Prior Medical History (Comparison Group: No) | |||||
Yes | 0.870 | 0.699 | 1.083 | 0.150 | 0.213 |
History of Congestive Heart Failure (Comparison Group: No) | |||||
Yes | 0.947 | 0.865 | 1.036 | 0.335 | 0.235 |
History of Chronic Kidney Disease‡ (Comparison Group: No) | |||||
Yes | 0.809 | 0.714 | 0.915 | 0.480 | 0.001 |
History of End Stage Renal Disease (Comparison Group: No) | |||||
Yes | 1.418 | 1.038 | 1.937 | 0.420 | 0.029 |
Listed for Heart Transplant (Comparison Group: No) | |||||
Yes | 0.485 | 0.160 | 1.473 | 0.056 | 0.202 |
Taking ARNI Prior to Hospitalization (Comparison Group: No) | |||||
Yes | 9.488 | 6.752 | 13.333 | 0.881 | <0.001 |
Contraindication to ACEi/ARB/ARNI (Comparison Group: No) | |||||
Yes | 0.113 | 0.104 | 0.124 | 0.347 | <0.001 |
Received inpatient ARNI (Comparison Group: No) | |||||
Yes | 72.091 | 58.301 | 89.142 | 0.846 | <0.001 |
Received any inpatient inotrope (Comparison Group: No) | |||||
Yes | 0.527 | 0.436 | 0.637 | 0.093 | <0.001 |
Discharged with GDMT BB (Comparison Group: No) | |||||
Yes | 1.818 | 1.634 | 2.022 | 0.237 | <0.001 |
Discharged with ACEi or ARB (Comparison Group: No) | |||||
Yes | 0.098 | 0.088 | 0.109 | 0.551 | <0.001 |
Discharged with MRA (Comparison Group: No) | |||||
Yes | 1.773 | 1.636 | 1.922 | 0.386 | <0.001 |
Scheduled Follow Up on Discharge (Comparison Group: No) | |||||
Yes | 1.172 | 1.001 | 1.373 | 0.261 | 0.050 |
Discharged to Continued Care|| (Comparison Group: No) | |||||
Yes | 0.771 | 0.703 | 0.846 | 0.516 | <0.001 |
Year of Discharge (Comparison Group: Discharged in 2017) | |||||
2018 | 1.378 | 1.261 | 1.505 | 0.131 | <0.001 |
2019 | 1.831 | 1.678 | 1.999 | 0.138 | <0.001 |
2020 | 2.055 | 1.835 | 2.301 | 0.140 | <0.001 |
Heart Transplant Center (Comparison Group: No) | |||||
Yes | 0.555 | 0.347 | 0.887 | 0.023 | 0.014 |
Academic Center§ (Comparison Group: No) | |||||
Yes | 1.178 | 0.939 | 1.478 | 0.068 | 0.158 |
Intercept | 0.100 | 0.075 | 0.134 | 0.298 | <0.001 |
Results obtained via mixed-effect logistic regression model with a random intercept assigned to hospital site. Missing data were handled by multilevel multiple imputation. Coefficients and 95% confidence intervals are presented as odds ratios. Unless otherwise indicated by an asterisk, odds ratios are relative to the defined comparison group. Variables denoted by a single asterisk (*) are continuous variables and indicate a change in the odds ratio per 1-unit change in the continuous variable, with the exception of (†) ejection fraction, where the estimate indicates the change in odds ratio per 5% change in ejection fraction. Lambda indicates the proportion of variation due to missing data.
All continuous variables have been grand mean centered, so the intercept can be interpreted as the odds of being prescribed an ARNI with all categorical variables assuming their baseline comparison group value and all continuous variables at their mean value. (‡) A history of chronic kidney disease is defined by the GWTG data dictionary as a serum creatinine >2mg/dL. (§) Academic centers were defined by the presence of resident post-graduate physicians. (||) For the variable “Discharged to Continued Care”, continued care is defined as home health care, skilled nursing facility, inpatient rehabilitation, intermediate care facility, long term acute care facility, or another acute care facility.
ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin-receptor blocker; ARNI: angiotensin receptor-neprilysin inhibitor; BB: beta blocker; GDMT: guideline-directed medical therapy; HR: heart rate; K: potassium, MRA: mineralocorticoid receptor angtagonist; sBP: systolic blood pressure.